Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: A retrospective chart review

AbstractBackground:A significant proportion of autogenous vein grafts fail in the long term. Currently, there is no treatment to improve graft patency.Objective:This study was designed to assess the effectiveness of eicosapentaenoic acid (EPA) to prevent late failure of an autogenous vein graft and other perioperative risk factors affecting long-term patency.Methods:A retrospective chart review was performed on grafts of patients who underwent infrainguinal bypass surgery using autogenous vein grafts for peripheral arterial disease in a lower limb. Patients were stratified by the perioperative use of EPA. The EPA group was those patients who administered EPA ≥1 time within 3 months of surgery. The non-EPA group was made up of those patients who did not administer EPA within 3 months of surgery. Primary, assisted primary, and secondary patency rates of the grafts in each group were calculated by the Kaplan-Meier method and compared by the log-rank test. To evaluate the effect of other perioperative risk factors, a Cox proportional hazards analysis was performed.Results:One hundred sixty-one grafts were analyzed from 159 patients who underwent surgery between July 1991 and July 2005. The primary patency rates of the EPA and non-EPA groups were 93% and 86%, 89% and 74%, and 83% and 68% at 1, 3, and 5 years, respectively. In terms of primary patency, the EPA group was significantly better than the non-EPA group (P=0.042). There was no significant difference between the groups in either assisted primary or secondary patency. A Cox proportional hazard analysis found that the minimum graft diameter and perioperative use of EPA were significant factors for primary patency (P=0.002 and P=0.004, respectively). Graft diameter was the only significant factor for assisted primary and secondary patency (P=0.021 and P=0.003, respectively).Conclusion:Although graft diameter was the most important factor for long-term patency of infrainguinal vein bypass grafts, the perioperative use of EPA significantly improved primary patency among these subjects

On the contribution of twist-3 multi-gluon correlation functions to single transverse-spin asymmetry in SIDIS

We study the single spin asymmetry (SSA) induced by purely gluonic correlation inside a nucleon, in particular, by the three-gluon correlation functions in the transversely polarized nucleon, $p^\uparrow$. This contribution is embodied as a twist-3 mechanism in the collinear factorization framework and controls the SSA to be observed in the $D$-meson production with large transverse-momentum in semi-inclusive DIS (SIDIS), $ep^\uparrow \rightarrow eDX$. We define the relevant three-gluon correlation functions in the nucleon, and determine their complete set at the twsit-3 level taking into account symmetry constraints in QCD. We derive the single-spin-dependent cross section for the $D$-meson production in SIDIS, taking into account all the relevant contributions at the twist-3 level. The result is obtained in a manifestly gauge-invariant form as the factorization formula in terms of the three-gluon correlation functions and reveals the five independent structures with respect to the dependence on the azimuthal angle for the produced $D$ meson. We also demonstrate the remarkable relation between the twist-3 single-spin-dependent cross section and twist-2 cross sections for the $D$-meson production, as a manifestation of universal structure behind the SSA in a variety of hard processes.Comment: 8 pages, 2 figures. To appear in the proceedings of the 19th International Spin Physics Symposium (SPIN2010), Juelich, Germany, Sept.27 - Oct.2, 201

Oxidative Modification to Cysteine Sulfonic Acid of Cys111 in Human Copper-Zinc Superoxide Dismutase

Copper-zinc superoxide dismutase (SOD1) plays a protective role against oxidative stress. On the other hand, recent studies suggest that SOD1 itself is a major target of oxidative damage and has its own pathogenicity in various neurodegenerative diseases, including familial amyotrophic lateral sclerosis. Only human and great ape SOD1s among mammals have the highly reactive free cysteine residue, Cys111, at the surface of the SOD1 molecule. The purpose of this study was to investigate the role of Cys111 in the oxidative damage of the SOD1 protein, by comparing the oxidative susceptibility of recombinant human SOD1 modified with 2-mercaptoethanol at Cys111 (2-ME-SOD1) to wild-type SOD1. Wild-type SOD1 was more sensitive to oxidation by hydrogen peroxide-generating fragments, oligomers, and charge isomers compared with 2-ME-SOD1. Moreover, wild-type SOD1, but not 2-ME-SOD1, generated an upper shifted band in reducing SDS-PAGE even by air oxidation. Using mass spectrometry and limited proteolysis, this upper band was identified as an oxidized subunit of SOD1; the sulfhydryl group (Cys-SH) of Cys111 was selectively oxidized to cysteine sulfinic acid (Cys-SO2H) and to cysteine sulfonic acid (Cys-SO3H). The antibody raised against a synthesized peptide containing Cys111-SO3H reacted with only the Cys111-peroxidized SOD1 by Western blot analysis and labeled Lewy bodylike hyaline inclusions and vacuole rims in the spinal cord of human SOD1-mutated amyotrophic lateral sclerosis mice by immunohistochemical analysis. These results suggest that Cys111 is a primary target for oxidative modification and plays an important role in oxidative damage to human SOD1, including familial amyotrophic lateral sclerosis mutants.This work was supported by Grants-in-aid for Scientific Research 17500242 and 19500313; a Hitech Research Center grant and the 21st Century Centers of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and in part by a Grant for the Research Group on Development of Novel Therapeutics for ALS from the Ministry of Health, Labor and Welfare of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact

An automated distinction of DICOM image for lung cancer CAD system

Automated distinction of medical images is an important preprocessing in Computer-Aided Diagnosis (CAD) systems. The CAD systems have been developed using medical image sets with specific scan conditions and body parts. However, varied examinations are performed in medical sites. The specification of the examination is contained into DICOM textual meta information. Most DICOM textual meta information can be considered reliable, however the body part information cannot always be considered reliable. In this paper, we describe an automated distinction of DICOM images as a preprocessing for lung cancer CAD system. Our approach uses DICOM textual meta information and low cost image processing. Firstly, the textual meta information such as scan conditions of DICOM image is distinguished. Secondly, the DICOM image is set to distinguish the body parts which are identified by image processing. The identification of body parts is based on anatomical structure which is represented by features of three regions, body tissue, bone, and air. The method is effective to the practical use of lung cancer CAD system in medical sites

Identification of nesfatin-1 as a satiety molecule in the hypothalamus

The brain hypothalamus contains certain secreted molecules that are important in regulating feeding behaviour. Here we show that nesfatin, corresponding to NEFA/nucleobindin2 (NUCB2), a secreted protein of unknown function, is expressed in the appetite-control hypothalamic nuclei in rats. Intracerebroventricular (i.c.v.) injection of NUCB2 reduces feeding. Rat cerebrospinal fluid contains nesfatin-1, an amino-terminal fragment derived from NUCB2, and its expression is decreased in the hypothalamic paraventricular nucleus under starved conditions. I.c.v. injection of nesfatin-1 decreases food intake in a dose-dependent manner, whereas injection of an antibody neutralizing nesfatin-1 stimulates appetite. In contrast, i.c.v. injection of other possible fragments processed from NUCB2 does not promote satiety, and conversion of NUCB2 to nesfatin-1 is necessary to induce feeding suppression. Chronic i.c.v. injection of nesfatin-1 reduces body weight, whereas rats gain body weight after chronic i.c.v. injection of antisense morpholino oligonucleotide against the gene encoding NUCB2. Nesfatin-1-induced anorexia occurs in Zucker rats with a leptin receptor mutation, and an anti-nesfatin-1 antibody does not block leptin-induced anorexia. In contrast, central injection of alpha-melanocyte-stimulating hormone elevates NUCB2 gene expression in the paraventricular nucleus, and satiety by nesfatin-1 is abolished by an antagonist of the melanocortin-3/4 receptor. We identify nesfatin-1 as a satiety molecule that is associated with melanocortin signalling in the hypothalamus

Mirrorfolds with K3 Fibrations

We study a class of non-geometric string vacua realized as completely soluble superconformal field theory (SCFT). These models are defined as `interpolating orbifolds' of $K3 \times S^1$ by the mirror transformation acting on the $K3$ fiber combined with the half-shift on the $S^1$-base. They are variants of the T-folds, the interpolating orbifolds by T-duality transformations, and thus may be called `mirrorfolds'. Starting with arbitrary (compact or non-compact) Gepner models for the $K3$ fiber, we construct modular invariant partition functions of general mirrorfold models. In the case of compact $K3$ fiber the mirrorfolds only yield non-supersymmetric string vacua. They exhibit IR instability due to winding tachyon condensation which is similar to the Scherk-Schwarz type circle compactification. When the fiber SCFT is non-compact (say, the ALE space in the simplest case), on the other hand, both supersymmetric and non-supersymmetric vacua can be constructed. The non-compact non-supersymmetric mirrorfolds can get stabilised at the level of string perturbation theory. We also find that in the non-compact supersymmeric mirrorfolds D-branes are {\em always} non-BPS. These D-branes can get stabilized against both open- and closed-string marginal deformations.Comment: Eqns (2.61) and (3.17) correcte

DNA Analysis from Biopsied Specimens for Carcinomas of the Esophagus

Surgical outcome for advanced esophageal cancer patients is not satisfactory in spite of improvements of diagnostic tools, operative techniques, postoperative cares and adjuvant chemotherapy. Postoperative prognosis used to be predicted by the grades of histologic disease progression. However, it is limited to accurate prediction of its prognosis. Recent studies have been focused on biologic behavior of malignant cells, in particular, nuclear DNA contents which play an important role in cell proliferation and metabolizm. Clinical use of flow-cytometric measurement of nuclear DNA is now prevalent to assess the grades of malignancy for malignant tumors. In contrast, it is difficult to know nuclear DNA contents preoperatively. The purpose of this study is to clarify whether or not preoperative biologic behaviors is clinically feasible, from biopsied specimens in comparison with that from the surgical specimens

A Randomized Controlled Trial of Comprehensive Early Intervention Care in Patients with First-Episode Psychosis in Japan: 1.5-year Outcomes from the J-CAP Study

The first episode of psychosis represents a critical period wherein comprehensive early intervention in psychosis (EIP) may alter the course of illness. However, evidence from randomized controlled trials that have examined the impact of comprehensive EIP care on clinical and functional recovery assessed by independent blinded raters is limited. The objective of this study was to conduct a single-blinded multicenter trial comparing comprehensive EIP care and standard care in young patients with first-episode psychosis (FEP) in Japan (J-CAP Study). A total of 77 participants with FEP (aged 15–35 years) were randomized to receive standard care or specialized comprehensive EIP care and were followed up for 1.5 years (trial no.: UMIN000005092). Function (measured with the Global Assessment of Functioning) and clinical remission (defined by internationally standardized criteria proposed by the Remission in Schizophrenia Working Group) were evaluated by independent raters who were blinded to group assignment. Dropout rate and other secondary outcomes were also examined. The specialized EIP care group had a higher clinical remission rate (odds ratio, 6.3; 95% confidence interval, 1.0–37.9) and lower treatment dropout rate (odds ratio, 0.038; 95% confidence interval, 0.002–0.923) than the standard care group, even after adjusting for baseline characteristics. Functional improvement in the specialized EIP care group was slightly higher than that in the standard care group, but this difference was not statistically significant (p = 0.195). From the results, we conclude that comprehensive EIP care may provide advantages over standard care in patients with FEP